Correlation Between Kinder Morgan and AstraZeneca PLC

Can any of the company-specific risk be diversified away by investing in both Kinder Morgan and AstraZeneca PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kinder Morgan and AstraZeneca PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Kinder Morgan and AstraZeneca PLC, you can compare the effects of market volatilities on Kinder Morgan and AstraZeneca PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kinder Morgan with a short position of AstraZeneca PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kinder Morgan and AstraZeneca PLC.

Diversification Opportunities for Kinder Morgan and AstraZeneca PLC

-0.76

Correlation Coefficient

Kinder Morgan  AstraZeneca PLC

Pay attention - limited upside

The 3 months correlation between Kinder and AstraZeneca is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding Kinder Morgan and AstraZeneca PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AstraZeneca PLC and Kinder Morgan is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kinder Morgan are associated (or correlated) with AstraZeneca PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AstraZeneca PLC has no effect on the direction of Kinder Morgan i.e., Kinder Morgan and AstraZeneca PLC go up and down completely randomly.

Pair Corralation between Kinder Morgan and AstraZeneca PLC

Assuming the 90 days horizon Kinder Morgan is expected to under-perform the AstraZeneca PLC. In addition to that, Kinder Morgan is 1.23 times more volatile than AstraZeneca PLC. It trades about -0.27 of its total potential returns per unit of risk. AstraZeneca PLC is currently generating about -0.07 per unit of volatility. If you would invest  12,675  in AstraZeneca PLC on September 23, 2024 and sell it today you would lose (220.00) from holding AstraZeneca PLC or give up 1.74% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Kinder Morgan  vs.  AstraZeneca PLC

Kinder Morgan

Risk-Adjusted Performance

17 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Kinder Morgan are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Kinder Morgan reported solid returns over the last few months and may actually be approaching a breakup point.

AstraZeneca PLC

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days AstraZeneca PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest fragile performance, the Stock's technical and fundamental indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Pair Trading with Kinder Morgan and AstraZeneca PLC

The main advantage of trading using opposite Kinder Morgan and AstraZeneca PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kinder Morgan position performs unexpectedly, AstraZeneca PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AstraZeneca PLC will offset losses from the drop in AstraZeneca PLC's long position.

The idea behind Kinder Morgan and AstraZeneca PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.